Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new late-breaking data highlighting the clinical and economic ...

September, where the company offered insights into AI deployment in rail and emphasised the importance of multimodality in ...

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School ...

People who sleep with lights on face a 47% higher chance of having a heart attack compared to those who keep their nights ...

Efficacy of Icosapent Ethyl for Cardiovascular Risk Reduction by Aspirin Use in REDUCE-IT ...

Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...

While we already have an understanding of the trajectories of babies who undergo different surgical/interventional procedures ...

There are forearm-based heart rate monitors, wrist-based heart rate monitors, smartwatches, fitness trackers and even ...

The Sports Medicine industry is projected to grow significantly, reaching US$ 12.32 Billion by 2033 from US$ 7.27 Billion in ...

Originally, we analyzed and predicted refining margins manually using Excel, but now we’ve built a visualized data system by ...

Bayer announced today that data from across the KERENDIA (R) (finerenone) comprehensive clinical trial program will be presented in scientific sessions at the American Society of Nephrology (ASN) ...

The MarketWatch News Department was not involved in the creation of this content.-- Post hoc analyses include data showing investigational oral semaglutide 25 mg use was associate ...